This page is an automatically generated summary of information from the Federal Court, Federal Court of Appeal, Health Canada and other websites. This information should NOT be relied upon as it is automatically generated and has not been confirmed for accuracy.

Automatically generated on July 6, 2024.

Return to the list of Patented Medicine Litigation page.

---

---

Glatiramer

COPAXONE – Teva Neuroscience (NOC Search)

Patents:

• 2191088: MYLAN, TEVA
• 2702437: TEVA, MYLAN, PHARMASCIENCE, TEVA, SANDOZ, TEVA
• 2760802: TEVA, SANDOZ, MYLAN, TEVA, TEVA, PHARMASCIENCE, PHARMASCIENCE, TEVA

MYLAN, TEVA

• PM(NOC) – T-894-13
• Infringement – T-1485-20

PHARMASCIENCE, TEVA

• Appeal – A-4-21
• Other – 19-A-26
• PM(NOC) – A-159-21 (2022 FCA 207) – A-315-20 (2022 FCA 2) – A-316-20 – T-2182-18 (2019 FC 595, 2019 FC 1394, 2020 FC 1158)

SANDOZ, TEVA

• PM(NOC) – T-1479-18

TEVA, MYLAN

• Infringement – T-1486-20

TEVA, PHARMASCIENCE

• PM(NOC) – T-2183-18 (2021 FC 367)

TEVA, SANDOZ

• PM(NOC) – T-1478-18

---

Return to the Patented Medicine Litigation page.